Plant tissue culture

Segra International completes first export of Cannabis plantlets from Canada to the USA

Retrieved on: 
Tuesday, June 29, 2021
Psychoactive drugs, Entheogens, Euphoriants, Medicinal plants, Cannabis smoking, Branches of biology, Biology, Cannabis, Plantlet, Plant tissue culture, Effects of cannabis

Segras Verified Segra Stock plantlets will provide BRC with standardized and validated starting materials produced through plant tissue culture and backed by extensive agronomic data and Cannabis plant pathogen screening.

Key Points: 
  • Segras Verified Segra Stock plantlets will provide BRC with standardized and validated starting materials produced through plant tissue culture and backed by extensive agronomic data and Cannabis plant pathogen screening.
  • BRC works with research groups studying Cannabis and Cannabis flower to understand the plant in a scientific and federally regulated environment.
  • Segra's Verified Segra Stock guarantee means our plantlets are DNA fingerprinted and pathogen-free with virtually no risk of pathogen introduction to the receiving grow facility.
  • Segra has developed industrial-scale laboratories to produce Verified Segra Stock, robust, and DNA-fingerprinted Cannabis plantlets for licensed producers globally.

Segra International completes first export of Cannabis plantlets to Portugal for greenhouse cultivation trials with leading multi-national cannabis operator

Retrieved on: 
Thursday, June 10, 2021
Entheogens, Euphoriants, Medicinal plants, Branches of biology, Psychoactive drugs, Biology, Cannabis, Cannabis smoking, Plantlet, Plant tissue culture, Legality of cannabis

VANCOUVER, British Columbia, June 10, 2021 (GLOBE NEWSWIRE) -- Segra International Corp, a leading cannabis agriculture technology company, is pleased to announce its first successful shipment of numerous premium Cannabis tissue culture plantlets to Portugal for greenhouse cultivation trials with a leading multi-national cannabis operator.

Key Points: 
  • VANCOUVER, British Columbia, June 10, 2021 (GLOBE NEWSWIRE) -- Segra International Corp, a leading cannabis agriculture technology company, is pleased to announce its first successful shipment of numerous premium Cannabis tissue culture plantlets to Portugal for greenhouse cultivation trials with a leading multi-national cannabis operator.
  • This shipment represents the third country Segra has successfully exported plantlets to in 2021 along with South Africa and Germany.
  • Segra is an agriculture technology company offering plant tissue culture, plant genomics, and pathogen detection services to accelerate the advancement of the cannabis industry.
  • Segra has developed industrial-scale laboratories to produce Verified Segra Stock, robust, and DNA-fingerprinted cannabis plantlets for licensed producers globally.

Segra International Enters into Cannabis Cultivar Genetic Banking Agreement with Leading Canadian Producer to Preserve and Protect High-Value Cultivars

Retrieved on: 
Wednesday, June 9, 2021
Medicinal plants, Entheogens, Euphoriants, Branches of biology, Herbalism, Health sciences, Medicine, Cannabis smoking, Cannabis, Plant tissue culture, Medical cannabis

Under the Agreement, more than twenty high-value Cannabis cultivars have been selected, and the plant tissue culture process is currently underway at Segra's production lab located in New Westminster, BC.

Key Points: 
  • Under the Agreement, more than twenty high-value Cannabis cultivars have been selected, and the plant tissue culture process is currently underway at Segra's production lab located in New Westminster, BC.
  • Segra's tissue culture processes, pathogen detection tests, and quality control systems represent the emerging gold standard for modern Cannabis nursery operations.
  • "We are thrilled to begin this collaboration to help preserve and protect an award-winning proprietary Cannabis genetic portfolio for years to come," says Jamie Blundell, CEO of Segra.
  • Segra has developed industrial-scale laboratories to produce Verified Segra Stock, robust, and DNA-fingerprinted Cannabis plantlets for licensed producers globally.

Segra Enters Agreement to Deploy Plant Tissue Culture for Large Scale Outdoor Cannabis Cultivation in Collaboration with Leading Canadian Licensed Producer

Retrieved on: 
Wednesday, April 22, 2020
Plants, Entheogens, Euphoriants, Medicinal plants, Organisms, Cell culture, Plant tissue culture, Plantlet, Cannabis, Strawberry

Under the agreement, Segra will provide approximately 40,000 plantlets to the Licensed Producer for late spring planting.

Key Points: 
  • Under the agreement, Segra will provide approximately 40,000 plantlets to the Licensed Producer for late spring planting.
  • To Segras knowledge, this planting represents the first large scale outdoor deployment of cannabis plantlets derived directly from a plant tissue culture, anywhere in the world.
  • Most clonally produced crops in the world, from strawberries to orchids, have benefited immensely from plant tissue culture.
  • Segra is an agriculture technology company offering plant tissue culture and DNA fingerprinting services to accelerate the advancement of the cannabis industry.

Segra enters into Strategic Plant Genotyping and Tissue Culture Agreement with Sugarbud

Retrieved on: 
Thursday, December 5, 2019
Plants, Plant reproduction, Cell culture, Plant tissue culture, Micropropagation, Cultivar, Canna

VANCOUVER, British Columbia, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Segra International Corp. ("Segra") is pleased to announce that it has entered into a strategic plant genotyping and tissue culture agreement with Sugarbud Craft Growers Corp. (TSXV: SUGR, SUGR.WT, SUGR.RT) ("Sugarbud") through its wholly owned subsidiary Segra Biogenesis Corp.

Key Points: 
  • VANCOUVER, British Columbia, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Segra International Corp. ("Segra") is pleased to announce that it has entered into a strategic plant genotyping and tissue culture agreement with Sugarbud Craft Growers Corp. (TSXV: SUGR, SUGR.WT, SUGR.RT) ("Sugarbud") through its wholly owned subsidiary Segra Biogenesis Corp.
  • Under the terms of the agreement, which includes royalties tied to production success, Segra will provide Sugarbud with exclusive and proprietary cannabis cultivars as well as tissue culture technology and services for the preservation, regeneration, and production of key cultivars already held by Sugarbud.
  • Plant tissue culture, also known as plant micropropagation, is an advanced scientific technique utilized in many commercial agricultural applications to mass-produce plants with desirable traits.
  • To support this vision, Segra has assembled a world-class team of specialists in the fields of agronomy, molecular genetics, plant tissue culture, and regulatory compliance.

Sugarbud enters into Strategic Plant Genotyping and Tissue Culture Agreement with Segra

Retrieved on: 
Thursday, December 5, 2019
Plants, Plant reproduction, Cell culture, Plant tissue culture, Micropropagation, Cultivar, Canna

CALGARY, Alberta, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Sugarbud Craft Growers Corp. (TSXV: SUGR, SUGR.WT, SUGR.RT) ("Sugarbud") is pleased to announce that it has entered into a strategic plant genotyping and tissue culture agreement with Segra Biogenesis Corp., a wholly owned subsidiary of Segra International Corp. ("Segra").

Key Points: 
  • CALGARY, Alberta, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Sugarbud Craft Growers Corp. (TSXV: SUGR, SUGR.WT, SUGR.RT) ("Sugarbud") is pleased to announce that it has entered into a strategic plant genotyping and tissue culture agreement with Segra Biogenesis Corp., a wholly owned subsidiary of Segra International Corp. ("Segra").
  • Under the terms of the agreement, which include royalties tied to production success, Segra will provide Sugarbud with exclusive and proprietary cannabis cultivars as well as tissue culture technology and services for the preservation, regeneration, and production of key cultivars already held by Sugarbud.
  • Plant tissue culture, also known as plant micropropagation, is an advanced scientific technique utilized in many commercial agricultural applications to mass-produce plants with desirable traits.
  • To support this vision, Segra has assembled a world-class team of specialists in the fields of agronomy, molecular genetics, plant tissue culture, and regulatory compliance.

Segra Awarded Nursery License from Health Canada for its Flagship Cannabis Tissue Culture Nursery

Retrieved on: 
Tuesday, November 26, 2019
Medicinal plants, Medicine, Entheogens, Euphoriants, Herbalism, Plants, Health sciences, Cannabis, Cannabis smoking, Plant tissue culture, Medical cannabis

VANCOUVER, British Columbia, Nov. 26, 2019 (GLOBE NEWSWIRE) -- Segra International Corp., an agriculture technology company, is pleased to announce that it has received a Cannabis Nursery License from Health Canada for the companys flagship cannabis tissue culture nursery located in New Westminster, BC.

Key Points: 
  • VANCOUVER, British Columbia, Nov. 26, 2019 (GLOBE NEWSWIRE) -- Segra International Corp., an agriculture technology company, is pleased to announce that it has received a Cannabis Nursery License from Health Canada for the companys flagship cannabis tissue culture nursery located in New Westminster, BC.
  • In addition to certified nursery stock, the company offers services for the regeneration and preservation of cannabis cultivars, as well as DNA fingerprinting analytical services.
  • Plant tissue culture has already solved the propagation challenge for hundreds of other crops ranging from strawberries to ferns.
  • Under this new Nursery License, the companys distribution is not limited to Canada, and Segra expects to begin exporting plantlets to other federally legal jurisdictions soon.